Company Investors
In addition to its founders, Pharmalink is backed by two of the Nordic region’s largest venture investors.

Pharmalink’s founders Bengt Julander and Mikael Bender remain as investors through their respective holding companies.

Industrifonden is one of Sweden’s largest and most experienced investors in early stage and in growth companies, and manages an evergreen fund of approximately SEK3.5 billion (EUR420m). It has for the last 30 years had a leading role in the development of Swedish life science companies. Founded by the Swedish government in 1979, Industrifonden is an independent venture capital fund that operates on a strictly commercial basis and receives no further government funding. Revenues are returned to the business for new investments. (www.industrifonden.se)


Investinor is Norway’s largest investor in venture and expansion capital, and manages a NOK4.2 billion (EUR525m) evergreen fund.  Investinor was founded in 2008 and is funded by the Norwegian government. It invests directly in promising unlisted companies and on the same terms and conditions as private investors, with a clear exit strategy for all investments.  (www.investinor.no)